Prosecution Insights
Last updated: April 19, 2026

Charles Landrum

19 pending office actions • 11 clients

Portfolio Summary

19
Total Pending OAs
3
Final Rejections
16
Non-Final OAs

Client Portfolio (11 clients)

Client (Assignee)Pending OAs
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 7
Pneumocyte, LLC 2
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2
Groupe Nature Pharma 1
Board Of Regents, The Universtiy Of Texas System 1
The University of North Texas Health Science Center at Fort Worth 1
Bexar Biomedical 1
Laurie E. Sower 1
Servicio Andaluz De Salud 1
The Board Of Regents Of The University Of Texas Sy 1
Plus Therapeutics, Inc. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19205984 INTEGRATED SMART SYSTEM CONTROLLABLE BY ASYNCHRONOUS EEG BASED BRAINCOMPUTER INTERFACE USING RIEMANNIAN GEOMETRY USING EMBEDDED ROBOTOPERATING SYSTEM BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM BALAOING, ARIEL A 2624 Non-Final OA May 12, 2025
18659926 COMPOSITIONS COMPRISING NATURAL PRODUCTS FOR IMPROVING CARBOHYDRATE AND LIPID METABOLISM Groupe Nature Pharma BOWERS, ERIN M 1653 Non-Final OA May 09, 2024
18623004 Portable Lead Smartwatch Electrocardiography Apparatus and Methods of Use Pneumocyte, LLC MINCHELLA, ADAM ZACHARY 3794 Non-Final OA Mar 31, 2024
18603110 Microrobotic Systems and Methods for Endovascular Interventions Board Of Regents, The Universtiy Of Texas System KISH, JAMES M 3792 Non-Final OA Mar 12, 2024
18570151 Method to Identify Patterns in Brain Activity BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM MALAMUD, DEBORAH LESLIE 3792 Non-Final OA Dec 14, 2023
18504509 METHODS, APPARATUSES, AND SYSTEMS FOR ASPIRATING AIRWAYS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM LE, QUYNH DAO 3781 Non-Final OA Nov 08, 2023
18558765 INDANONE AND TETRALONEKETO OR HYDROXYL OXIMES AS CANCER THERAPEUTICS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM MOTEVALLI, OROD 1628 Non-Final OA Nov 03, 2023
18280427 Loading of Alginate Microspheres BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM BAEK, JONGHWAN NMN 1618 Non-Final OA Sep 05, 2023
18237368 DESIGN AND CHARACTERIZATION OF INHIBITORY PEPTIDES (IPEPS) DERIVED FROM OF MIEN 1 PROTEIN SEQUENCE The University of North Texas Health Science Center at Fort Worth JAUHARI, SACHI 1654 Non-Final OA Aug 23, 2023
18210829 LIVE ATTENUATED ZIKA VIRUS WITH 3'UTR DELETION, VACCINE CONTAINING AND USE THEREOF BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM SALVOZA, M FRANCO G 1672 Non-Final OA Jun 16, 2023
18010852 BITE BLOCK FOR RESPIRATORY AND DIAGNOSTIC ENDOSCOPIC EQUIPMENT Pneumocyte, LLC TEIXEIRA MOFFAT, JONATHAN CHARLES 3700 Non-Final OA Dec 16, 2022
17928248 IMPLANTABLE INTRATHECAL DRUG DELIVERY SYSTEM FOR CHRONIC PAIN CONTROL Bexar Biomedical MENDEZ, MANUEL A 3783 Non-Final OA Nov 28, 2022
17917754 TP508 ACUTE THERAPY FOR PATIENTS WITH RESPIRATORY VIRUS INFECTION Laurie E. Sower FAN, LYNN Y 1759 Final Rejection Oct 07, 2022
17795223 SALICYLAMIDE DERIVATIVES AND RELATED METHODS OF MAKING Servicio Andaluz De Salud RAO, SAVITHA M 1691 Non-Final OA Jul 25, 2022
17776803 COMPOSITIONS AND METHODS FOR CONTROLLED DELIVERY AND PROTECTION OF THERAPEUTIC AGENTS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM PRAGANI, RAJAN 1614 Final Rejection May 13, 2022
17769181 ENDOTRACHEAL TUBE The Board Of Regents Of The University Of Texas Sy LOUIS, LATOYA M 3785 Non-Final OA Apr 14, 2022
17611929 RADIOTHERAPEUTIC MICROSPHERES Plus Therapeutics, Inc. YOUNG, MICAH PAUL 1618 Final Rejection Nov 17, 2021
17355290 METHODS AND COMPOSITIONS RELATED TO EXTRACELLULAR VESICLES BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM ROGERS, ERIC JASON 1638 Non-Final OA Jun 23, 2021
17331723 ELECTROANALYTICAL DETERMINATION OF LEUKOCYTE ESTERASE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM SELWANES, JOHN PAUL 1651 Non-Final OA May 27, 2021

Managing Charles Landrum's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month